Skip to main content
. 2003 Oct;56(4):395–406. doi: 10.1046/j.1365-2125.2003.01888.x

Figure 4.

Figure 4

Mean PRA before and after administration of omapatrilat in the multiple-dose study. Concentrations were higher at 4 than at 0 h and appeared to be dose-dependent. At all doses, PRA was elevated for less than 24 h postdose on day 1. Placebo (□); 10 mg (Inline graphic); 25 mg (Inline graphic); 50 mg (Inline graphic); 75 mg (Inline graphic); and 125 mg (▪).